{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:22Z","timestamp":1791932362601,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA124737"],"award-info":[{"award-number":["CA124737"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA161048"],"award-info":[{"award-number":["CA161048"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA175577"],"award-info":[{"award-number":["CA175577"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.virol.2014.10.035","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T22:03:31Z","timestamp":1416521011000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector"],"prefix":"10.1016","volume":"475","author":[{"given":"Guido","family":"Wollmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Paglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian A.","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony N.","family":"van den Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.virol.2014.10.035_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/vim.2004.17.516","article-title":"Vesicular stomatitis virus as an oncolytic vector","volume":"17","author":"Barber","year":"2004","journal-title":"Viral Immunol."},{"issue":"3","key":"10.1016\/j.virol.2014.10.035_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/NMM:7:3:217","article-title":"Failed central nervous system regeneration: a downside of immune privilege?","volume":"7","author":"Bechmann","year":"2005","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.virol.2014.10.035_bib4","doi-asserted-by":"crossref","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","article-title":"A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon","volume":"6","author":"Berger Rentsch","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymthe.2005.02.017","article-title":"IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes","volume":"12","author":"Berraondo","year":"2005","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.virol.2014.10.035_bib6","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1128\/jvi.69.10.6466-6472.1995","article-title":"Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity","volume":"69","author":"Bi","year":"1995","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2014.10.035_bib7","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/jvi.69.4.2208-2213.1995","article-title":"Inhibition of vesicular stomatitis virus infection by nitric oxide","volume":"69","author":"Bi","year":"1995","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/viro.2000.0562","article-title":"NSAID treatment suppresses VSV propagation in mouse CNS","volume":"276","author":"Chen","year":"2000","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2014.10.035_bib9","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/JVI.01911-06","article-title":"Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations","volume":"81","author":"Clarke","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.035_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/jvi.37.3.1060-1065.1981","article-title":"Effects of chloroquine and cytochalasin B on the infection of cells by Sindbis virus and vesicular stomatitis virus","volume":"37","author":"Coombs","year":"1981","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.meegid.2004.06.006","article-title":"Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus","volume":"5","author":"Cuevas","year":"2005","journal-title":"Infect. Genet. Evol."},{"issue":"2","key":"10.1016\/j.virol.2014.10.035_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/viro.2000.0736","article-title":"Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles","volume":"279","author":"Dalton","year":"2001","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.virol.2014.10.035_bib13","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.0602460103","article-title":"Neurons produce type I interferon during viral encephalitis","volume":"103","author":"Delhaye","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.virol.2014.10.035_bib14","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4049\/jimmunol.0800596","article-title":"Local type I IFN receptor signaling protects against virus spread within the central nervous system","volume":"182","author":"Detje","year":"2009","journal-title":"J. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.virol.2014.10.035_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1099\/0022-1317-62-1-91","article-title":"Inhibition of vesicular stomatitis virus glycoprotein expression by chloroquine","volume":"62","author":"Dille","year":"1982","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virol.2014.10.035_bib16","doi-asserted-by":"crossref","first-page":"e1002712","DOI":"10.1371\/journal.ppat.1002712","article-title":"Interferon-induced Ifit2\/ISG54 protects mice from lethal VSV neuropathogenesis","volume":"8","author":"Fensterl","year":"2012","journal-title":"PLoS Pathog."},{"issue":"13","key":"10.1016\/j.virol.2014.10.035_bib17","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1128\/JVI.75.13.6107-6114.2001","article-title":"Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development","volume":"75","author":"Flanagan","year":"2001","journal-title":"J. Virol."},{"issue":"Pt 1","key":"10.1016\/j.virol.2014.10.035_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2001.0237b.x","article-title":"Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus","volume":"533","author":"Gao","year":"2001","journal-title":"J. Physiol."},{"issue":"Suppl. 3","key":"10.1016\/j.virol.2014.10.035_bib19","doi-asserted-by":"crossref","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virol.2014.10.035_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/AAC.2.3.201","article-title":"Inhibition of vesicular stomatitis virus replication by 9-beta-d-arabinofuranosyladenine","volume":"2","author":"Grant","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.virol.2014.10.035_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.virol.2014.10.035_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1099\/0022-1317-27-3-395","article-title":"Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice","volume":"27","author":"Gresser","year":"1975","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2014.10.035_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0092-8674(90)90163-9","article-title":"Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated","volume":"63","author":"Harada","year":"1990","journal-title":"Cell"},{"issue":"Pt 12","key":"10.1016\/j.virol.2014.10.035_bib24","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1099\/vir.0.046672-0","article-title":"Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer","volume":"93","author":"Hastie","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2014.10.035_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2009.05.024","article-title":"Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter","volume":"286","author":"He","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.virol.2014.10.035_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-0348-8171-5_2","article-title":"Pleiotropic mechanisms of ribavirin antiviral activities","volume":"59","author":"Hong","year":"2002","journal-title":"Prog. Drug Res."},{"issue":"2","key":"10.1016\/j.virol.2014.10.035_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7705\/biomedica.v29i2.18","article-title":"Therapy of rabies encephalitis","volume":"29","author":"Jackson","year":"2009","journal-title":"Biomedica"},{"issue":"10","key":"10.1016\/j.virol.2014.10.035_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.patbio.2006.07.008","article-title":"Evaluation by Q-RTPCR of the efficacy of ribavirin complexed with beta-cyclodextrin against measles virus in a mouse encephalitis model","volume":"54","author":"Jeulin","year":"2006","journal-title":"Pathol. Biol. (Paris)"},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2006.10.026","article-title":"Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates","volume":"360","author":"Johnson","year":"2007","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.virol.2014.10.035_bib30","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1128\/JVI.01093-12","article-title":"Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice","volume":"86","author":"Kallfass","year":"2012","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2014.10.035_bib31","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1021\/jm950891z","article-title":"Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2","volume":"39","author":"Kolocouris","year":"1996","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.virol.2014.10.035_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"Lichty","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.virol.2014.10.035_bib33","series-title":"Fields Virology","article-title":"Rhabdoviridae","author":"Lyles","year":"2007"},{"key":"10.1016\/j.virol.2014.10.035_bib34","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/mt.2008.168","article-title":"Preventing growth of brain tumors by creating a zone of resistance","volume":"16","author":"Maguire","year":"2008","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.virol.2014.10.035_bib35","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2174\/092986707780597907","article-title":"Interferon: cellular executioner or white knight?","volume":"14","author":"Maher","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.virol.2014.10.035_bib36","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1073\/pnas.80.7.1929","article-title":"Inhibitors of endocytosis perturb phospholipid metabolism in rabbit neutrophils and other cells","volume":"80","author":"Mato","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.virol.2014.10.035_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1570162033485320","article-title":"Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases","volume":"1","author":"McKenna","year":"2003","journal-title":"Curr. HIV Res."},{"issue":"8","key":"10.1016\/j.virol.2014.10.035_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/cgt.2009.8","article-title":"Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta","volume":"16","author":"Meijer","year":"2009","journal-title":"Cancer Gene Ther."},{"issue":"11","key":"10.1016\/j.virol.2014.10.035_bib39","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1128\/JVI.02511-10","article-title":"Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism","volume":"85","author":"Muik","year":"2011","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2014.10.035_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00109-012-0863-6","article-title":"Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy","volume":"90","author":"Muik","year":"2012","journal-title":"J. Mol. Med."},{"issue":"22","key":"10.1016\/j.virol.2014.10.035_bib41","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1128\/JVI.02558-08","article-title":"Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain","volume":"83","author":"Ozduman","year":"2009","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2014.10.035_bib42","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1523\/JNEUROSCI.4905-07.2008","article-title":"Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain","volume":"28","author":"Ozduman","year":"2008","journal-title":"J. Neurosci."},{"issue":"6\u20137","key":"10.1016\/j.virol.2014.10.035_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.biochi.2007.02.009","article-title":"Type I interferon response in the central nervous system","volume":"89","author":"Paul","year":"2007","journal-title":"Biochimie"},{"issue":"Pt 10","key":"10.1016\/j.virol.2014.10.035_bib44","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1099\/0022-1317-75-10-2595","article-title":"Involvement of the vacuolar H(+)-ATPase in animal virus entry","volume":"75","author":"P\u00e9rez","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2014.10.035_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0076-6879(86)19004-5","article-title":"Interferon standards and general abbreviations","volume":"119","author":"Pestka","year":"1986","journal-title":"Methods Enzymol."},{"issue":"17","key":"10.1016\/j.virol.2014.10.035_bib46","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1128\/JVI.78.17.9317-9324.2004","article-title":"Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses","volume":"78","author":"Publicover","year":"2004","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.virol.2014.10.035_bib47","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2014.10.035_bib48","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2014.10.035_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.virol.2014.10.035_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2004.02.011","article-title":"Intranasal administration of interferon beta bypasses the blood\u2013brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis","volume":"151","author":"Ross","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.virol.2014.10.035_bib51","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.79.7.2291","article-title":"Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin","volume":"79","author":"Schlegel","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0042-6822(80)90131-2","article-title":"Inhibition of vesicular stomatitis virus replication by adenosine","volume":"103","author":"Schnitzlein","year":"1980","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2014.10.035_bib53","doi-asserted-by":"crossref","first-page":"e11265","DOI":"10.1371\/journal.pone.0011265","article-title":"Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin","volume":"5","author":"Shah","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2014.10.035_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.virol.2014.10.035_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.virol.2014.10.035_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0042-6822(81)90088-X","article-title":"The effects of adenosine and guanosine on the replication of Sindbis and vesicular stomatitis viruses in Aedes albopictus cells","volume":"115","author":"Stollar","year":"1981","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cgt.7700878","article-title":"Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta","volume":"13","author":"Streck","year":"2006","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.virol.2014.10.035_bib58","first-page":"69","article-title":"Effect of amantadine on rhabdovirus infection","volume":"11","author":"Superti","year":"1985","journal-title":"Drugs Exp. Clin. Res."},{"issue":"6","key":"10.1016\/j.virol.2014.10.035_bib59","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1083\/jcb.102.6.2244","article-title":"Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells","volume":"102","author":"Tedeschi","year":"1986","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.virol.2014.10.035_bib60","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.29.6.1010","article-title":"Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells","volume":"29","author":"Toltzis","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2014.10.035_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2006.07.010","article-title":"Antiviral effect of octyl gallate against DNA and RNA viruses","volume":"73","author":"Uozaki","year":"2007","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.virol.2014.10.035_bib62","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/JVI.76.3.1309-1327.2002","article-title":"Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein","volume":"76","author":"van den Pol","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2014.10.035_bib63","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JVI.01106-12","article-title":"Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity","volume":"87","author":"van den Pol","year":"2013","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2014.10.035_bib64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/cne.22131","article-title":"Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression","volume":"516","author":"van den Pol","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.virol.2014.10.035_bib65","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1128\/JVI.03509-13","article-title":"Long distance interferon signaling within the brain blocks virus spread","volume":"88","author":"van den Pol","year":"2014","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virol.2014.10.035_bib66","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1128\/JVI.79.13.8295-8302.2005","article-title":"Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2014.10.035_bib67","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1056\/NEJMoa050382","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2014.10.035_bib68","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.03311-12","article-title":"Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes","volume":"87","author":"Wollmann","year":"2013","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2014.10.035_bib69","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1128\/JVI.01861-06","article-title":"Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells","volume":"81","author":"Wollmann","year":"2007","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2014.10.035_bib70","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JVI.02040-09","article-title":"Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells","volume":"84","author":"Wollmann","year":"2010","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2014.10.035_bib71","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1128\/JVI.79.10.6005-6022.2005","article-title":"Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential","volume":"79","author":"Wollmann","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2014.10.035_bib72","first-page":"685","article-title":"Antiviral effect of octyl gallate against influenza and other RNA viruses","volume":"19","author":"Yamasaki","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"11","key":"10.1016\/j.virol.2014.10.035_bib73","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/cgt.2013.63","article-title":"Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV","volume":"20","author":"Yarde","year":"2013","journal-title":"Cancer Gene Ther."},{"issue":"1\u20132","key":"10.1016\/j.virol.2014.10.035_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2012.06.009","article-title":"Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells","volume":"168","author":"Ye","year":"2012","journal-title":"Virus Res."},{"issue":"19","key":"10.1016\/j.virol.2014.10.035_bib75","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1128\/JVI.01209-09","article-title":"Similarities and differences in antagonism of neuron alpha\/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses","volume":"83","author":"Yin","year":"2009","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2014.10.035_bib76","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1349-7006.2004.tb02194.x","article-title":"Interferon-beta gene therapy for cancer: basic research to clinical application","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214004929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682214004929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:28:11Z","timestamp":1758587291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682214004929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":75,"alternative-id":["S0042682214004929"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2014.10.035","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2014.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}